- Home
- HRMY vs SONO Comparison
HRMY vs SONO Comparison
Compare HRMY & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- SONO
- Stock Information
- Founded
- HRMY 2017
- SONO 2002
- Country
- HRMY United States
- SONO United States
- Employees
- HRMY N/A
- SONO N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- SONO Consumer Electronics/Video Chains
- Sector
- HRMY Health Care
- SONO Consumer Discretionary
- Exchange
- HRMY Nasdaq
- SONO Nasdaq
- Market Cap
- HRMY 2.0B
- SONO 1.8B
- IPO Year
- HRMY 2020
- SONO 2018
- Fundamental
- Price
- HRMY $39.05
- SONO $14.00
- Analyst Decision
- HRMY Strong Buy
- SONO Buy
- Analyst Count
- HRMY 8
- SONO 2
- Target Price
- HRMY $55.00
- SONO $17.50
- AVG Volume (30 Days)
- HRMY 593.9K
- SONO 2.0M
- Earning Date
- HRMY 02-20-2025
- SONO 02-06-2025
- Dividend Yield
- HRMY N/A
- SONO N/A
- EPS Growth
- HRMY N/A
- SONO N/A
- EPS
- HRMY 2.11
- SONO N/A
- Revenue
- HRMY $681,879,000.00
- SONO $1,518,056,000.00
- Revenue This Year
- HRMY $24.79
- SONO N/A
- Revenue Next Year
- HRMY $19.00
- SONO $8.82
- P/E Ratio
- HRMY $18.55
- SONO N/A
- Revenue Growth
- HRMY 25.83
- SONO N/A
- 52 Week Low
- HRMY $28.14
- SONO $10.23
- 52 Week High
- HRMY $41.61
- SONO $19.76
- Technical
- Relative Strength Index (RSI)
- HRMY 71.30
- SONO 41.24
- Support Level
- HRMY $35.72
- SONO $13.89
- Resistance Level
- HRMY $37.16
- SONO $15.01
- Average True Range (ATR)
- HRMY 1.29
- SONO 0.55
- MACD
- HRMY 0.48
- SONO -0.15
- Stochastic Oscillator
- HRMY 92.25
- SONO 41.25
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
About SONO Sonos Inc.
Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.